Drreddys Laboratories | RDY - الربح الإجمالي على المبيعات





الربح الإجمالي على المبيعات تغيير تاريخ
ANI Pharmaceuticals USD 124.18M 12.39M 2025-12
Aurora Cannabis CAD 46.62M 14.33M 2025-12
Bayer EUR 5.35B 1.02B 2025-09
Canopy Growth CAD 21.47M 434K 2025-12
Cipla INR 41.64B 6.31B 2025-12
Corcept Therapeutics USD 199.58M 3.46M 2025-12
Drreddys Laboratories INR 46.81B 10.24B 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Lonza CHF 1.29B 248M 2025-06
Novartis USD 10.25B 570M 2025-12
Pacira USD 142.25M 11.34M 2025-12
Phibro Animal Health USD 133.5M 12.6M 2025-12
Prestige Brands USD 157.37M 5.79M 2025-12
Richter Gedeon HUF 143.37B 25.78B 2025-09
Sun Pharmaceuticals INR 107.66B 2.05B 2025-09
Supernus Pharmaceuticals USD 164.04M 15.23M 2025-12
Teva Pharmaceutical Industries USD 2.66B 351M 2025-12